Genes for common diseases
The genetics of essential hypertension
Drug treatment of obesity: from past failures to future successes?
Effect of dexmedetomidine, an α 2 -adrenoceptor agonist, on human pupillary reflexes during general anaesthesia
Pharmacodynamic models for the cardiovascular effects of moxonidine in patients with congestive heart failure
Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol
Trans-3′-hydroxycotinine: Disposition kinetics, effects and plasma levels during cigarette smoking
Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy
Population modelling of the effect of inogatran, at thrombin inhibitor, on ex vivo coagulation time (APTT) in healthy subjects and patients with coronary artery disease
Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting
Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning
Co-prescribing of SSRIs and TCAs in Australia: how often does it occur and who is doing it?
Effect of α 1 -acid glycoprotein on the intracellular accumulation of the HIV protease inhibitors saquinavir, ritonavir and indinavir in vitro
Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations
Terbinafine-associated inhibition of dextromethorphan metabolism in Chinese subjects